tiprankstipranks
Trevi Therapeutics reports Q3 EPS (8c), consensus (9c)
PremiumThe FlyTrevi Therapeutics reports Q3 EPS (8c), consensus (9c)
6M ago
Trevi Therapeutics Announces Third Quarter 2023 Financial Results and Provides Business Update
PremiumPress Releases
Trevi Therapeutics Announces Third Quarter 2023 Financial Results and Provides Business Update
6M ago
Trevi Therapeutics initiates Phase 2a RIVER clinical trial of Haduvio
PremiumThe Fly
Trevi Therapeutics initiates Phase 2a RIVER clinical trial of Haduvio
6M ago
Trevi Therapeutics files $200M mixed securities shelf
PremiumThe FlyTrevi Therapeutics files $200M mixed securities shelf
10M ago
Trevi Therapeutics Announces First Quarter 2023 Financial Results and Provides Business Update
PremiumPress Releases
Trevi Therapeutics Announces First Quarter 2023 Financial Results and Provides Business Update
12M ago
TRVI Earnings this Week: How Will it Perform?
PremiumPre-Earnings
TRVI Earnings this Week: How Will it Perform?
12M ago
Trevi receives notice of allowance from USPTO for nalbuphine ER’s method
PremiumThe FlyTrevi receives notice of allowance from USPTO for nalbuphine ER’s method
1y ago
Trevi Therapeutics names David Clark as chief medical officer
PremiumThe Fly
Trevi Therapeutics names David Clark as chief medical officer
1y ago
Trevi Therapeutics reports Q3 EPS (12c), consensus (13c)
PremiumThe Fly
Trevi Therapeutics reports Q3 EPS (12c), consensus (13c)
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100